Asthma The Pathopysiology of Asthma What happens in the body to give rise to symptoms By Pat Bass, MD twitter linkedin Dr. Bass is a board-certified internist, pediatrician, and a Fellow of the American Academy of Pediatrics and the American College of Physicians. Learn about our editorial process Pat Bass, MD Medically reviewed by Medically reviewed by Daniel More, MD on December 01, 2019 Daniel More, MD, is a board-certified allergist and clinical immunologist with a background in internal medicine. Learn about our Medical Review Board Daniel More, MD Updated on January 23, 2021 Print The pathophysiology of asthma—that is, the processes it entails—involves multiple organs, systems, and mechanisms. While these differ somewhat from one type of asthma to the next, the end result is the same: bronchoconstriction, inflammation, and mucus overproduction that make it harder for you to breathe. What sets all of this into motion, asthma's pathogenesis, is equally complex. Learning more about how asthma comes about can help you better understand how various treatments and management approaches can minimize asthma's impact on your life and why your doctor may recommend one over another. Ed Reschke / Getty Images Pathophysiology of Asthma Pathophysiology is the way in which a disease alters the normal function of your body. The term is derived from Greek prefix pathos, meaning "suffering," and the root physiologia, meaning "natural philosophy." The pathophysiology of asthma involves: HypersensitivityHyperresponsiveness to stimuliBronchoconstriction and inflammationIn severe cases, airway remodeling Hypersensitivity People with asthma are known to be hypersensitive to things called triggers. What this means is that the immune system incorrectly perceives certain stimuli, such as dust or pollen, to be harmful. This sensitivity is what causes allergies and sensitivities. Common allergens include: Dust mitesAnimal dander or furMoldPollenCertain foods (e.g., peanuts, milk, eggs)Certain drugs (e.g., penicillin, cephalosporin antibiotics, anti-inflammatories) Common sensitivities include: SmokeDustAir pollutionStrong odorsWorkplace chemicals How Irritants Trigger Asthma Hyperresponsiveness to Stimuli In people without asthma, the airways relax when an irritant is breathed in to help expel it. In asthma, the airways don't relax and actually get smaller. This is called hyperresponsiveness, and it's somewhat like a twitch in your airways that's especially easy to induce. The narrowing of the airways makes it more difficult to breathe. When you use your rescue inhaler, you feel better because the medication relaxes your airways and makes them larger so that air can flow more easily. Hyperresponsiveness occurs soon after exposure to an allergen and is the first part of an asthma attack. Changes that occur later that have more to do with inflammation. Bronchoconstriction and Inflammation Hyperresponsiveness causes your bronchial tubes to contract. At the same time, inflammatory cells and chemicals flood your airways and cause inflammation, which further restricts your breathing and can become chronic. Bronchoconstriction and inflammation combine with excess production of mucus, which exacerbates breathing difficulty and leads to a chronic cough that works to release the mucus. Bronchospasm typically lasts for one to two hours before resolving. In some cases, however, it may appear to resolve only to have an attack occur up to 12 hours later. Asthma symptoms may be present only on occasion or all the time, depending on your asthma severity. Asthma exacerbations, or attacks, involve a more extreme tightening of the airways that makes it hard to breathe and can be life-threatening. All About Bronchoconstriction Airway Remodeling In more severe cases, chronic inflammation can lead to a process called airway remodeling in which the walls of the air passages thicken and harden, the glands enlarge, and networks of blood vessels grow rapidly and abnormally. While less severe asthma is considered reversible with proper treatment and management, airway remodeling is currently irreversible. It's associated with worsened symptoms and more frequent and severe asthma attacks. Asthma's Long-Term Impact on Health Pathogenesis of Asthma Taking a step back, all of this begins with a changes that occur at the cellular level. Hypersensitivity prompts an activation of the immune system and starts a complex chain reaction involving numerous cells and substances. This mechanism includes an early phase and a late phase. The early phase begins when your immune system detects allergens or irritants in your body. In response, plasma cells release an antibody called immunoglobulin E (IgE). Antibodies are specialized cells that attack and try to destroy things your body perceives as threats. The IgE then attaches itself to several types of white blood cells, which can vary due to the type of asthma. Mast Cells Mast cells are especially prevalent in certain areas of your body, including the lungs. Once IgE attaches to a mast cell, that cell will respond to the presence of an allergen by releasing: Cytokines: Proteins that drive inflammatory processes through interferons, interleukins, and tumor necrosis factor-alpha (TNF-α)Histamine: A chemical messenger that dilates blood vessels, drives inflammation, causes symptoms of an allergic reaction (itchy, watery eyes and sore throat), and leads to bronchoconstriction and mucus productionProstaglandins: A compound involved in inflammation, mucus production, bronchoconstriction, and airway remodelingLeukotrienes: Chemicals that include highly potent bronchoconstrictorsPlatelet-activating factor (PAF): A substance tied to anaphylaxis, which is a severe and potentially life-threatening allergic reaction, and that may reduce the effectiveness of allergy medications Mast Cells' Role in Your Health Basophils Basophils perform a number of important functions, perhaps the most important of which is in certain inflammatory reactions, particularly those involving allergies. Basophils are a part of the innate immune system, which triggers a non-specific reaction to anything the body considers harmful. Unlike adaptive immunity, which elicits a targeted response, innate immunity results in a generalized attack that involves inflammation, swelling, pain, fever, and fatigue. Basophils, like mast cells, produce histamine, leukotrienes, and PAF. Having too many basophils in your blood (basophilia) can be a powerful driver of asthma symptoms, including: Severe inflammation of the lungsBronchoconstrictionExcessive production of mucus, causing coughing and respiratory obstruction Basophils are especially implicated in allergic asthma. How Basophils Influence Your Asthma Eosinophils Eosinophils are less involved in allergic asthma and associated more with their own subtype, called eosinophilic asthma (e-asthma). E-asthma is often severe and comes on most often in adulthood. While it involves an allergic response, many people with this type of asthma don't actually have allergies. Eosinophils: Contain inflammatory chemicalsCreate leukotrienes (which increase bronchoconstriction)Express numerous cytokines (which drive inflammation) E-asthma is believed to be associated with a set of symptoms not present with other asthma types, including: Chronic rhinosinusitisNasal polypsEnlarged mucus membranes in the nasal passagesLoss of smell When chronic rhinosinusitis and nasal polyps accompany asthma, they can predispose you to aspirin-induced asthma. When all three conditions are present, they are collectively known as Samter's Triad. Understanding E-Asthma Neutrophils People with severe asthma that doesn't respond well to treatment with corticosteroid medications often have high levels of neutrophils. Their condition is sometimes referred to as neutrophilic asthma. Produced in the bone marrow, neutrophils are first-line responders. They destroy allergens and other invading organisms (viruses, bacteria) by surrounding and ingesting them. Neutrophils are part of an acute inflammatory response. They: Activate and regulate several immune cellsSupport chronic inflammationRelease an array of cytokines and PAFRelease thromboxane, a hormone that constricts the smooth muscles of the airways They're involved in both the innate and adaptive immune response as well. White Blood Cells and Immunity T Helper 2 Cells T helper 2 (Th2) cells do as their name suggests: They support other cells in several ways, including assisting with their activation. Of course, in asthma, these key players in the immune response are what help trigger asthma symptoms: GM-CSF: This cytokine tells stem cells to produce basophils, eosinophils, and neutrophils, which help sustain inflammation.Interleukins: These immune-response regulators help keep basophils and eosinophils alive; one of them contributes to airway remodeling and thickening. Macrophages Like neutrophils, macrophages are made in your bone marrow and engulf foreign substances to destroy them. In asthma, macrophages release substances that initiate and prolong hyperresponsiveness of the airways, increase mucus production and swelling, and attract eosinophils to the lung. These substances include: PAFProstaglandinsThromboxane Macrophages can ultimately increase asthma symptoms. Late Phase The late phase of asthma occurs over the next few hours, as many of these cells make their way to the lungs, causing increased bronchoconstriction and inflammation, which makes it harder for you to breathe. Neutrophils, eosinophils, and Th2 cells are especially believed to be a part of the late-phase response. These cells can be found in the sputum of people with asthma and may be associated with severe exacerbations. Impact on Asthma Treatment While there is no cure for asthma, treatments can control its symptoms and slow (if not entirely stop) its progression. With the pathogenesis and pathophysiology of asthma in mind, doctors can recommend strategies to either minimize or normalize the response, or prevent it from happening. Certain medications target specific cells and the processes they're involved in, which is why it's so important for doctors to pinpoint exactly what's going on in the body, including the minute cellular changes and the broader system-wide effects. Some classes of medications used for treating asthma include: Mast cell stabilizersLeukotriene modifiersAntihistaminesBronchodilators Mast Cell Stabilizers Mast cell stabilizers are medications for allergic asthma that reduce inflammation by preventing mast cells from releasing histamine and other inflammatory chemicals. Some mast cell stabilizers used as asthma treatment are: Intal/Gastocrom (cromolyn)Tilade (nedocromil) Cromolyn for Treating Asthma Leukotriene Modifiers Leukotrienes directly influence bronchoconstriction and airway inflammation as part of the body's allergic response, and leukotriene modifiers prevent that from happening. Some common leukotriene modifiers prescribed for asthma include: Accolate (zafirlukast)Singulair (motelukast)Zyflo (zileuton) Antihistamines The most common medications for allergies are antihistamines, and these drugs can play a role in treating allergic asthma, as well. Primarily, antihistamines are used to prevent the allergic responses that can lead to asthma attacks. Because antihistamines aren't the only chemicals involved in the inflammation and bronchoconstriction of asthma, they're generally not the only treatment needed for complete asthma control. Antihistamines are available by prescription or over-the-counter. Some common antihistamines include: Allegra (fexofenadine)Benadryl (diphenhydramine)Clarinex (desloratadine) Claritin (loratadine)Xyzal (levocetirizine) Zyrtec (cetirizine) Antihistamines for Allergies and Asthma Bronchodilators Bronchodilator medications help relax the muscles of the airways. Short-acting bronchodilators, often called rescue inhalers, are used to end asthma attacks or to prevent EIB. Long-acting bronchodilators are taken regularly to prevent attacks. These medications, and especially rescue inhalers, are a mainstay of asthma treatment, regardless of type, because all types include bronchoconstriction. Common short-acting bronchodilators include: Ventolin/Proair/Proventil (albuterol)Xopenex (levalbuterol) Some long-acting bronchodilators are: Salmetrol (available in the combination drug Advair)Performomist (formoterol)Atrovent (ipratropium)Theochron (theophylline) Bronchodilators: Types and Uses Taking Control of Asthma In the end, the course of the disease is not inevitable and can be altered with the appropriate use of medications and lifestyle management, including: Taking long-term control medications as prescribedKeeping your rescue inhaler handy for when you need itAvoiding triggers that cause asthma attacksGetting vaccinated against the flu or pneumonia (so symptoms aren't compounded by other causes of breathing difficulties)Making lifestyle choices that improve lung function, including diet, exercise, and not smokingVisiting your doctor regularly so they can monitor your respiratory health and manage medications to keep your asthma well controlled An Overview of Asthma Treatment A Word From Verywell The nitty-gritty about what makes asthma come about may ultimately seem most relevant to your doctor. And to a large extent, that is true. That said, it hopefully gives you a better sense of what is happening in your body and why certain treatments and management approaches are working (and worth committing to) and why others are not. Doing what you can to influence the early part of the cascade of events that bring about asthma symptoms can help you live well with your condition. Was this page helpful? Thanks for your feedback! Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life. Sign Up You're in! Thank you, {{form.email}}, for signing up. There was an error. Please try again. What are your concerns? Other Inaccurate Hard to Understand Submit Article Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Castillo JR, Peters SP, Busse WW. Asthma exacerbations: Pathogenesis, prevention, and treatment. J Allergy Clin Immunol Pract. 2017;5(4):918-927. doi:10.1016/j.jaip.2017.05.001 Zhou-Suckow Z, Duerr J, Hagner M, Agrawal R, Mall MA. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases. Cell Tissue Res. 2017;367(3):537-550. doi:10.1007/s00441-016-2562-z Yamauchi K, Inoue H. Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling. Allergol Int. 2007;56(4):321-9. doi:10.2332/allergolint.R-07-151 Ferreira VL, Borba HH, Bonetti ADF, Leonart LP, Pontarolo R. Cytokines and interferons: Types and functions. Autoantibodies and Cytokines. 2019. doi:10.5772/intechopen.74550 Yamauchi K, Ogasawara M. The role of histamine in the pathophysiology of asthma and the clinical efficacy of antihistamines in asthma therapy. Int J Mol Sci. 2019;20(7) doi:10.3390/ijms20071733 Lee K, Lee SH, Kim TH. The biology of prostaglandins and their role as a target for allergic airway disease therapy. Int J Mol Sci. 2020;21(5):1851. Published 2020 Mar 8. doi:10.3390/ijms21051851 Al-Azzam N, Elsalem L. Leukotriene D4 role in allergic asthma pathogenesis from cellular and therapeutic perspectives. Life Sci. 2020;260:118452. doi:10.1016/j.lfs.2020.118452 Ulambayar B, Yang EM, Cha HY, Shin YS, Park HS, Ye YM. Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study. Clin Transl Allergy. 2019;9:33. Published 2019 Jul 17. doi:10.1186/s13601-019-0275-6 Siracusa MC, Kim BS, Spergel JM, Artis D. Basophils and allergic inflammation. J Allergy Clin Immunol. 2013;132(4):789-788. doi:10.1016/j.jaci.2013.07.046 de Groot JC, ten Brinke A, Bel EH. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 2015;1(1):00024-2015-. doi:10.1183/23120541.00024-2015 Ray A, Kolls JK. Neutrophilic inflammation in asthma and association with disease severity. Trends Immunol. 2017;38(12):942-954. doi:10.1016/j.it.2017.07.003 Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519-531. Published 2011 Jul 25. doi:10.1038/nri3024 Rucker D, Dhamoon AS. Physiology, thromboxane A2. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 13, 2020. Fahy JV. Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol. 2015;15(1):57-65. doi:10.1038/nri3786 Quirt J, Hildebrand KJ, Mazza J, Noya F, Kim H. Asthma. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):50. doi:10.1186/s13223-018-0279-0 Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. Br J Pharmacol. 2013;170(1):23-37. doi:10.1111/bph.12138 Singh RK, Tandon R, Dastidar SG, Ray A. A review on leukotrienes and their receptors with reference to asthma. J Asthma. 2013;50(9):922-931. doi:10.3109/02770903.2013.823447 Yamauchi K, Ogasawara M. The role of histamine in the pathophysiology of asthma and the clinical efficacy of antihistamines in asthma therapy. Int J Mol Sci. 2019;20(7). doi:10.3390/ijms20071733 Price D, Fletcher M, Van der molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009. doi:10.1038/npjpcrm.2014.9 Additional Reading Lynn S, Kushto-Reese K. Understanding asthma pathophysiology, diagnosis, and management. American Nursing Today. 2015;10(7):49-51.